News

Eli Lilly, Navitas, Red Cat, Mr. Cooper, Rocket, Liberty Energy, Rio Tinto, and DeFi Development. Gavin Newsom defies Senate ...
Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...
Cigna's pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.
Over the past six months, Eli Lilly has earned significant wins over its Denmark-based rival and is still at it. Recent clinical trial results Eli Lilly released suggest that it is building a lead in ...
The Tobias and Lechleiter families donated $20 million to establish the Institute for Clinical Innovation at IU Health, the ...
Eli Lilly (LLY) stock in focus as the company beats Biogen (BIIB) to win regulatory nod in Australia for first ...
Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...
Global pharmaceutical giant Eli Lilly & Co. is seeking tax incentives for a potential 236-acre biomanufacturing plant in ...
As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have ...
Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Should you invest $1,000 in Eli Lilly right now? Stock Advisor analyst team just identified what ...
Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.
The obesity drug helped patients reduce their waist size by an extra two inches compared to those on Novo Nordisk’s Wegovy in ...